Patent EP0051415A1 successfully refreshed from Google Patents.
EP0051415A1
Expired / Lapsed
EP
⏱️ 0.0 years remaining
Water-soluble salts of 2,4-diamino-5-methyl-6-((3,4,5-trimethoxyanilino)methyl)quinazoline, compositions containing such salts and the production of such salts
Assignee: Warner Lambert Co LLC
•
Filing: 1981-10-26
•
Granted: —
•
Expires: 2001-10-26
Abstract
Abstract There are disclosed the monoisethionate and glucuronate salts of 2,4-diamino-5-methyl-6-[(3,4,5-trimethoxyanilino)-methyl] quinazoline, pharmaceutical compositions containing such salts and the production of such salts. The salts are suitable for treating malaria, bacterial infections, psoriasis and tumors. The salts have good water-solubility and other characteristics which are advantageous compared with known salts of the quinazoline base.
Inventors
- 👤 Norman Lloyd Colbry
Bibliographic Details
Application Number
—
Jurisdiction
EP
Data Source
google_patents
Last Synchronized
2026-11-06 11:57
CPC Classifications
C; C07; C07D; C07D239/00; C07D239/70; C07D239/72; C07D239/95; A; A61; A61P; A61P31/00; A61P31/04; A61P33/00; A61P33/02; A61P35/00; Y; Y02; Y02A; Y02A50/00; Y02A50/30
Claims Analysis
Total Claims: 5
Claim 1
Independent Claim
33 words
A process for preparing a compound having the following formula: wherein Z is 2-hydroxyethanesulphonicacid or glucuronic acid, which process comprises reacting a compound of the following formula with 2-hydroxyethanesulphonic acid or glucuronic acid.
Claim 2
Dependent Claim
33 words
A process for preparing a compound having the following formula: wherein Z is 2-hydroxyethanesulphonicacid or glucuronic acid, which process comprises reacting a compound of the following formula with 2-hydroxyethanesulphonic acid or glucuronic acid.
Claim 3
Dependent Claim
18 words
A process according to Claim 1, for producing the compound having the name 2,4-diamino-5-methyl-6-[(3, 4, 5- trimethoxyanilino)methyl]quinazoline monoisethionate.
Claim 4
Dependent Claim
15 words
A process according to Claim 1, for producing the compound having the name 2,4-diamino-5-methy16[(3,4,5-trimethoxyanilino)methyl]quinazoline glucuronate.
Claim 5
Dependent Claim
33 words
A process for producing a pharmaceutical composition comprising a therapeutically acceptable amount of a compound of formula I as shown in Claim 1, which comprises incorporating that compound in a pharmaceutically acceptable carrier.
References Cited (Backward Citations)
GB1345502A
Cited
USPTO Annuity & Maintenance Windows
Maintenance schedule is calculated for granted US utility patents.